Logo image of RENE.LS

REDES ENERGETICAS NACIONAIS (RENE.LS) Stock Fundamental Analysis

Europe - ELI:RENE - PTREL0AM0008 - Common Stock

2.948 EUR
-0.02 (-0.74%)
Last: 9/16/2025, 5:29:51 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to RENE. RENE was compared to 13 industry peers in the Multi-Utilities industry. RENE scores excellent on profitability, but there are concerns on its financial health. RENE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

RENE had positive earnings in the past year.
In the past year RENE had a positive cash flow from operations.
RENE had positive earnings in each of the past 5 years.
RENE had a positive operating cash flow in 4 of the past 5 years.
RENE.LS Yearly Net Income VS EBIT VS OCF VS FCFRENE.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

RENE has a better Return On Assets (4.24%) than 76.92% of its industry peers.
Looking at the Return On Equity, with a value of 14.86%, RENE is in line with its industry, outperforming 53.85% of the companies in the same industry.
RENE has a Return On Invested Capital of 8.52%. This is amongst the best in the industry. RENE outperforms 92.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RENE is in line with the industry average of 6.69%.
The last Return On Invested Capital (8.52%) for RENE is above the 3 year average (5.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.24%
ROE 14.86%
ROIC 8.52%
ROA(3y)2.39%
ROA(5y)2.2%
ROE(3y)9.02%
ROE(5y)8.34%
ROIC(3y)5.36%
ROIC(5y)4.97%
RENE.LS Yearly ROA, ROE, ROICRENE.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

RENE has a better Profit Margin (14.10%) than 92.31% of its industry peers.
RENE's Profit Margin has been stable in the last couple of years.
RENE has a better Operating Margin (24.00%) than 92.31% of its industry peers.
RENE's Operating Margin has declined in the last couple of years.
RENE's Gross Margin of 69.97% is amongst the best of the industry. RENE outperforms 92.31% of its industry peers.
In the last couple of years the Gross Margin of RENE has declined.
Industry RankSector Rank
OM 24%
PM (TTM) 14.1%
GM 69.97%
OM growth 3Y-3.06%
OM growth 5Y-5.7%
PM growth 3Y8.45%
PM growth 5Y-0.44%
GM growth 3Y-2.57%
GM growth 5Y-2.77%
RENE.LS Yearly Profit, Operating, Gross MarginsRENE.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

RENE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, RENE has about the same amount of shares outstanding.
RENE has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for RENE has remained at the same level compared to a year ago.
RENE.LS Yearly Shares OutstandingRENE.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
RENE.LS Yearly Total Debt VS Total AssetsRENE.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

RENE has an Altman-Z score of 0.79. This is a bad value and indicates that RENE is not financially healthy and even has some risk of bankruptcy.
RENE has a Altman-Z score of 0.79. This is amonst the worse of the industry: RENE underperforms 84.62% of its industry peers.
RENE has a debt to FCF ratio of 6.44. This is a slightly negative value and a sign of low solvency as RENE would need 6.44 years to pay back of all of its debts.
RENE has a Debt to FCF ratio of 6.44. This is amongst the best in the industry. RENE outperforms 100.00% of its industry peers.
RENE has a Debt/Equity ratio of 1.00. This is a neutral value indicating RENE is somewhat dependend on debt financing.
The Debt to Equity ratio of RENE (1.00) is better than 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 6.44
Altman-Z 0.79
ROIC/WACC1.47
WACC5.79%
RENE.LS Yearly LT Debt VS Equity VS FCFRENE.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

RENE has a Current Ratio of 0.23. This is a bad value and indicates that RENE is not financially healthy enough and could expect problems in meeting its short term obligations.
RENE has a Current ratio of 0.23. This is amonst the worse of the industry: RENE underperforms 84.62% of its industry peers.
RENE has a Quick Ratio of 0.23. This is a bad value and indicates that RENE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of RENE (0.23) is worse than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
RENE.LS Yearly Current Assets VS Current LiabilitesRENE.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

RENE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.51%, which is quite impressive.
Measured over the past 5 years, RENE shows a small growth in Earnings Per Share. The EPS has been growing by 5.29% on average per year.
The Revenue has grown by 8.08% in the past year. This is quite good.
Measured over the past years, RENE shows a small growth in Revenue. The Revenue has been growing by 5.57% on average per year.
EPS 1Y (TTM)24.51%
EPS 3Y16.26%
EPS 5Y5.29%
EPS Q2Q%28.57%
Revenue 1Y (TTM)8.08%
Revenue growth 3Y7.16%
Revenue growth 5Y5.57%
Sales Q2Q%7.53%

3.2 Future

RENE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.91% yearly.
The Revenue is expected to grow by 1.55% on average over the next years.
EPS Next Y4.84%
EPS Next 2Y7.28%
EPS Next 3Y5.39%
EPS Next 5Y-0.91%
Revenue Next Year7.58%
Revenue Next 2Y5.83%
Revenue Next 3Y4.26%
Revenue Next 5Y1.55%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RENE.LS Yearly Revenue VS EstimatesRENE.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
RENE.LS Yearly EPS VS EstimatesRENE.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.05 0.1 0.15 0.2

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.51 indicates a reasonable valuation of RENE.
Compared to the rest of the industry, the Price/Earnings ratio of RENE is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.20, RENE is valued rather cheaply.
RENE is valuated correctly with a Price/Forward Earnings ratio of 12.88.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RENE is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, RENE is valued a bit cheaper.
Industry RankSector Rank
PE 9.51
Fwd PE 12.88
RENE.LS Price Earnings VS Forward Price EarningsRENE.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

RENE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RENE is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.25
EV/EBITDA N/A
RENE.LS Per share dataRENE.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RENE does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of RENE may justify a higher PE ratio.
PEG (NY)1.96
PEG (5Y)1.8
EPS Next 2Y7.28%
EPS Next 3Y5.39%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.30%, RENE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.17, RENE pays a better dividend. On top of this RENE pays more dividend than 84.62% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, RENE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.3%

5.2 History

The dividend of RENE decreases each year by -2.07%.
Dividend Growth(5Y)-2.07%
Div Incr Years0
Div Non Decr Years1
RENE.LS Yearly Dividends per shareRENE.LS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

RENE pays out 46.50% of its income as dividend. This is a bit on the high side, but may be sustainable.
The Dividend Rate of RENE has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP46.5%
EPS Next 2Y7.28%
EPS Next 3Y5.39%
RENE.LS Yearly Income VS Free CF VS DividendRENE.LS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M
RENE.LS Dividend Payout.RENE.LS Dividend Payout, showing the Payout Ratio.RENE.LS Dividend Payout.PayoutRetained Earnings

REDES ENERGETICAS NACIONAIS

ELI:RENE (9/16/2025, 5:29:51 PM)

2.948

-0.02 (-0.74%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)07-25 2025-07-25
Earnings (Next)11-13 2025-11-13
Inst Owners26.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.97B
Analysts73.33
Price Target3.27 (10.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.3%
Yearly Dividend0.15
Dividend Growth(5Y)-2.07%
DP46.5%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.39%
PT rev (3m)7.3%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.22%
EPS NY rev (3m)2.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)3.46%
Valuation
Industry RankSector Rank
PE 9.51
Fwd PE 12.88
P/S 1.26
P/FCF 5.25
P/OCF 2.92
P/B 1.33
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.31
EY10.52%
EPS(NY)0.23
Fwd EY7.77%
FCF(TTM)0.56
FCFY19.03%
OCF(TTM)1.01
OCFY34.28%
SpS2.34
BVpS2.22
TBVpS-4.2
PEG (NY)1.96
PEG (5Y)1.8
Profitability
Industry RankSector Rank
ROA 4.24%
ROE 14.86%
ROCE 9.86%
ROIC 8.52%
ROICexc 8.6%
ROICexgc N/A
OM 24%
PM (TTM) 14.1%
GM 69.97%
FCFM 24.02%
ROA(3y)2.39%
ROA(5y)2.2%
ROE(3y)9.02%
ROE(5y)8.34%
ROIC(3y)5.36%
ROIC(5y)4.97%
ROICexc(3y)5.82%
ROICexc(5y)5.45%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.21%
ROCE(5y)5.75%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y2.25%
ROICexc growth 5Y0.7%
OM growth 3Y-3.06%
OM growth 5Y-5.7%
PM growth 3Y8.45%
PM growth 5Y-0.44%
GM growth 3Y-2.57%
GM growth 5Y-2.77%
F-Score6
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 6.44
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 19.25%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 170.37%
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z 0.79
F-Score6
WACC5.79%
ROIC/WACC1.47
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)26.47%
Cap/Sales(5y)25.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.51%
EPS 3Y16.26%
EPS 5Y5.29%
EPS Q2Q%28.57%
EPS Next Y4.84%
EPS Next 2Y7.28%
EPS Next 3Y5.39%
EPS Next 5Y-0.91%
Revenue 1Y (TTM)8.08%
Revenue growth 3Y7.16%
Revenue growth 5Y5.57%
Sales Q2Q%7.53%
Revenue Next Year7.58%
Revenue Next 2Y5.83%
Revenue Next 3Y4.26%
Revenue Next 5Y1.55%
EBIT growth 1Y-3.54%
EBIT growth 3Y3.89%
EBIT growth 5Y-0.44%
EBIT Next Year106.64%
EBIT Next 3Y31.37%
EBIT Next 5Y18.75%
FCF growth 1Y266.54%
FCF growth 3Y-13.59%
FCF growth 5Y13.81%
OCF growth 1Y3500.4%
OCF growth 3Y-3.92%
OCF growth 5Y12.52%